Literature DB >> 25185853

TCF7L2 rs7903146 polymorphism and diabetic nephropathy association is not independent of type 2 diabetes--a study in a south Indian population and meta-analysis.

Hajarah Hussain, Vinu Ramachandran, Samathmika Ravi, Teena Sajan, Kiruthiha Ehambaram, Venkatesh Babu Gurramkonda, Gnanasambandan Ramanathan, Lakkakula Venkata Bhaskar1.   

Abstract

Diabetic nephropathy (DN) is a chronic microangiopathic complication of both type 1 (T1DM) and type 2 diabetes mellitus (T2DM). The TCF7L2 gene has been reported to be associated with type 2 diabetes risk. We aimed to investigate the impact of TCF7L2 gene on the susceptibility of T2DM and DN in a south Indian population. Plus to evaluate the association of rs7903146 in the TCF7L2 gene with T2DM in the Indian population. The subjects recruited for this included 55 diabetic cases with diabetic nephropathy, 68 diabetic cases without nephropathy, and 82 non-diabetic healthy controls. Genomic DNA was isolated from blood and genotyping of TCF7L2 rs7903146 was performed by PCR-RFLP analysis. A literature survey was carried out into the effect of rs7903146 on genetic susceptibility to T2DM in Indian populations and we then performed a meta-analysis in order to evaluate its association with T2DM. Analysis of TCF7L2 rs7903146 in normal controls and diabetics with or without nephropathy demonstrated that the 'T' allele is associated with both diabetes (p = 0.049) and DN (p = 0.024), but this association is not independent of T2DM. Meta-analysis showed that the mutant allele and genotypes are associated with T2DM in Indian populations. In summary, a significant association exists between the 'T' allele and DN, but this association is not independent of T2DM. Pooled meta-analysis of studies on rs7903146 and T2DM confirmed that rs7903146 is significantly associated with susceptibility to T2DM in Indian populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25185853     DOI: 10.5603/EP.2014.0041

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  8 in total

1.  Validation of the association of TCF7L2 and SLC30A8 gene polymorphisms with post-transplant diabetes mellitus in Asian Indian population.

Authors:  IImran Ali Khan; Parveen Jahan; Qurratulain Hasan; Pragna Rao
Journal:  Intractable Rare Dis Res       Date:  2015-05

Review 2.  The genetic side of diabetic kidney disease: a review.

Authors:  Jinfang Song; Jiang Ni; Xiaoxing Yin
Journal:  Int Urol Nephrol       Date:  2022-08-16       Impact factor: 2.266

3.  Type 2 Diabetes Mellitus and the Association of Candidate Genes in Asian Indian Population from Hyderabad, India.

Authors:  Imran Ali Khan; Subhadra Poornima; Parveen Jahan; Pragna Rao; Qurratulain Hasan
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 4.  The Susceptibility Genes in Diabetic Nephropathy.

Authors:  Ling Wei; Ying Xiao; Li Li; Xiaofen Xiong; Yachun Han; Xuejing Zhu; Lin Sun
Journal:  Kidney Dis (Basel)       Date:  2018-09-06

5.  Association of the Transcription Factor 7 Like 2 (TCF7L2) Polymorphism With Diabetic Nephropathy Risk: A Meta-Analysis.

Authors:  Zhenqian Fan; Qiliang Cai; Yu Chen; Xuying Meng; Fenglin Cao; Shaoxiong Zheng; Jianchao Guo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus.

Authors:  Weiyue Ding; Li Xu; Lejun Zhang; Zhijie Han; Qinghua Jiang; Zhe Wang; Shuilin Jin
Journal:  BMC Med Genet       Date:  2018-03-07       Impact factor: 2.103

7.  GenPop-An Online Tool to Analyze Human Population Genetic Data.

Authors:  B Arundhati Mahesh; E Kannan; G Dicky John Davis; P Venkatesan; P K Ragunath
Journal:  Bioinformation       Date:  2020-02-29

8.  Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy: A case-control study.

Authors:  Yan Zhuang; Fukun Niu; Defeng Liu; Juanjuan Sun; Xiaowei Zhang; Jian Zhang; Shuxia Guo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.